News

Although the yellow fever outbreak that has affected several Latin American countries has eased since the end of summer, health officials say new cases are still springing up in some areas.

The new Senate healthcare bill released last week has died on the vine, even before it was formally put forward for deliberation and vote.

Ebola virus tracking and mechanisms to detect threats to our national food supply are highlighted.

The FDA has approved Gilead Sciences’ Vosevi for the treatment of adults with chronic hepatitis C virus genotypes 1-6, without cirrhosis or with mild cirrhosis.

Researchers from the Maryland Department of Health and Mental Hygiene have found that pet owners are at increased risk of encountering ticks.

A research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.

The results of a new study reinforce the importance of performing stethoscope hygiene.

A team of investigators are dedicating their efforts to pinpointing a source of the E. coli outbreak that has sprung up on the Utah-Arizona border.

A study published in Oxford University Press evaluates the effectiveness of several HIV diagnostic tests.

A new study published by the Centers for Disease Control and Prevention indicates that patients receiving eculizumab can still contract meningitis, even if they have been vaccinated.

A new iteration of the American Health Care Act (AHCA), the challenge of sepsis in US hospitals, a predictive map that identifies which species are likely to harbor the next human virus, how one Canadian researcher mail-ordered his way to horsepox, and a focus on how gonorrhea is on the way to becoming untreatable comprise the top 5 articles of the week for the week.

The CDC offers further insight into the investigation of a Zika virus infection in a family member of the first Zika-related death in the continental United States.

A naturally occurring compound in plums has been found to block the entry of the hepatitis C virus into cultured liver cells.

A new report from the National Center for Health Statistics has found that too many adults aged 65 and older are missing out on important vaccinations.

What does the latest news of Stanford Healthcare safety failures really tell us?

New research suggests that a vaccine designed to protect against meningitis may also protect against gonorrhea infections.

Senate Majority Leader Mitch McConnell and his Republican colleagues have written and released a new version of the American Health Care Act (AHCA) that addresses many outstanding concerns, but will it be enough?

Although advances in HIV treatment mean many people with the condition are able to achieve viral suppression and display no outward signs of illness, kidney disease is still a fairly common occurrence in those who are infected.

A new study is the first to examine the epidemiology of multidrug-resistant tuberculosis in children in the United States.

The National Institutes of Health (NIH) is looking to determine whether Zika virus infection poses an additional risk in women whose pregnancies are already complicated by HIV.

Researchers from the University of Iowa have found that surgical site infections are seasonal.

With as many as 30 million new cases annually, resulting in more than 6 million deaths worldwide, new initiatives are focusing on an age-old problem—sepsis, and its related complications.

For the most challenging of microbial threats, one microbiologist is trying an old tactic in a new era.

Researchers from EcoHealth Alliance have developed a predictive “map” that identifies the zoonotic host species that are “likely to harbor the next human virus” and documents the regions of the world where they can be found.

Cases of antibiotic-resistant gonorrhea are on the rise, and the bacteria may soon become untreatable if new antibiotics and diagnostic tools are not developed.

Researchers from the University of Pittsburgh find a way to successfully treat a patient with ceftazidime-avibactam-resistant Klebsiella pneumoniae.

A group of researchers examine the feasibility of a low-resource behavioral intervention created to promote retention in HIV care.

In a new study from Amsterdam, researchers have found that patients who were recently treated with azithromycin showed increased resistance to treatment for Neisseria gonorrhoeae.